Â鶹AV

Home

Â鶹AV and Moderna to expand collaborations with new projects in Lipid Nanoparticle research

Published: 19 July 2023

Â鶹AV today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative...

Â鶹AV joins Moderna in battle against global health threats

Published: 24 March 2022

Â鶹AV has joined Moderna’s mRNA Access program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through...

Subscribe to Moderna RSS
Back to top